TYPE 1 DIABETES MELLITIS
Clinical trials for TYPE 1 DIABETES MELLITIS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITIS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new medicine called CNP-103 in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either CNP-103 or a placebo over 90 …
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New insulin pump system put to the test in 400-Person safety trial
Disease control Recruiting nowThis study checks if a new insulin pump (NMX8) is safe when used with a continuous glucose monitor in people with type 1 or type 2 diabetes. About 400 participants aged 7 to 85 will use their usual therapy with the sensor for up to 40 days, then use the new pump for 90 days. The …
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
New insulin candidate GZR33 faces off against degludec in early trial
Disease control Recruiting nowThis early-phase study is testing a new long-acting insulin called GZR33 in 12 adults with type 1 diabetes. The goal is to see how well it controls blood sugar compared to an existing insulin (degludec), and to check its safety and how the body processes it. Participants must be …
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: PHASE1 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated May 26, 2026 03:54 UTC